Wellbutrin and Diabetic gastroparesis - a phase IV clinical study of FDA data

Summary:

Diabetic gastroparesis is reported as a side effect among people who take Wellbutrin (bupropion hydrochloride), especially for people who are female, 40-49 old, also take Seroquel, and have Insomnia.

The phase IV clinical study analyzes which people have Diabetic gastroparesis when taking Wellbutrin. It is created by eHealthMe based on reports of 101,581 people who have side effects when taking Wellbutrin from the FDA, and is updated regularly.

What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 117,107 Wellbutrin users. Check the latest studies of Wellbutrin.

What is Diabetic gastroparesis?

Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes) is found to be associated with 155 drugs and 244 conditions by eHealthMe. Check the latest studies of Diabetic gastroparesis.

On Jul, 21, 2026

101,581 people reported to have side effects when taking Wellbutrin.
Among them, 15 people (0.01%) have Diabetic gastroparesis.

Could Wellbutrin cause Diabetic gastroparesis?

Among these 15 people:

What is the gender of people who have Diabetic gastroparesis when taking Wellbutrin? *

female: 60 %
male: 40 %

What is the age of people who have Diabetic gastroparesis when taking Wellbutrin? *

What are other drugs people take besides Wellbutrin? *

What are other side effects people have besides Diabetic gastroparesis? *

Diabetes: 12 people, 80.00%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 40.00%
Hyperglycemia (high blood sugar): 5 people, 33.33%
Type 2 Diabetes: 5 people, 33.33%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 33.33%
Abdominal Pain: 4 people, 26.67%
Pancreatitis (inflammation of pancreas): 4 people, 26.67%
Pancreatitis Chronic (chronic inflammation of pancreas): 3 people, 20.00%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 3 people, 20.00%
Neuropathy Peripheral (surface nerve damage): 3 people, 20.00%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 4 people, 26.67%
Insomnia (sleeplessness): 4 people, 26.67%
Swelling: 2 people, 13.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 13.33%
Pain: 2 people, 13.33%
Depressive Symptom: 2 people, 13.33%
Diabetes: 2 people, 13.33%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 13.33%
Sleep Disorder: 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin and have Diabetic gastroparesis?

- Check whether Diabetic gastroparesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Wellbutrin:

Wellbutrin (117,107 reports)

Browse all side effects of Wellbutrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetic gastroparesis:

Diabetic gastroparesis (155 drugs)

Browse all the conditions that are associated with Diabetic gastroparesis:

Diabetic gastroparesis (244 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride (the active ingredients of Wellbutrin) and Wellbutrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.